Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Novo Nordisk previously claimed to have been alarmed by "reports of medical spas, weight loss clinics, pharmacies, and other companies" selling compounded semaglutide to patients on the grounds ...

Lilly is tirzepatide’s patentholder and the manufacturer of the two branded versions of tirzepatide, Mounjaro® (for diabetes) and Zepbound® (for weight loss and, announced on December 20 ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

weight loss clinics, pharmacies, and other companies that it accuses of unlawfully making semaglutide. The company has claimed that compounded semaglutide with incorrect dosages and 'known and ...

From semaglutide-based weight loss treatments to testosterone replacement therapy ... Let’s check out the current pricing below: Compounded semaglutide injections: $297 per month (only $247 for the ...

Finding an effective weight loss program can have major health ... the FDA is allowing compounding pharmacies to make ...